Hilke Kracker

Statistics

Publications

Citations

387

H-Index

Active since

2015

Affiliations

Actelion (Switzerland)(Current)

University of Cologne

Healthcentric Advisors

University of Calgary

Leeds General Infirmary

Hilke Kracker is an author at Actelion (Switzerland) specializing in clinical pharmacology, clostridioides difficile infection treatment, and infectious diseases.

Publications per year

2015–2021

Publications

Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study

Ludwig Kappos, Robert J. Fox, Michel Burcklen et al. · JAMA Neurology · 2021 · 218 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +8

Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection

Thomas Louie, Carl Erik Nord, George H. Talbot et al. · Antimicrobial Agents and Chemotherapy · 2015 · 73 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials

Dale N. Gerding, Oliver A. Cornely, Simon Grill et al. · The Lancet Infectious Diseases · 2019 · 65 citations

Medicine, Infectious Diseases, Pharmacology +5

Susceptibility of<i>Clostridium difficile</i>isolates from a Phase 2 clinical trial of cadazolid and vancomycin in<i>C. difficile</i>infection

Dale N. Gerding, D. W. Hecht, Thomas Louie et al. · Journal of Antimicrobial Chemotherapy · 2015 · 31 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +13

1–4 of 4